// App-Quantinova.ai

BSH19‐PO‐157 : Use of antithrombin concentrate in acquired antithrombin deficiency in acutely unwell children receiving unfractionated heparin – a single centre experience

Researchers

Presenter

  • D. Jayakody Arachchillage

Principal Investigators

  • M. Gaspar

  • S. Owen

  • S. Makhecha

  • M. Laffan

Medical Centers

  • Department of Haematology, Royal Brompton Hospital

  • Department of Histopathology, Imperial College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Infectious Diseases (ID)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Thrombocytopenia

  • Tuberculosis

  • Venous thrombosis

Biomarkers

  • Activated partial thromboplastin time

Drug/Treatment

  • Heparin

  • Fibrinogen (IV)

  • folitixorin calcium

  • Heparin

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved